Search results for "Microbial Pathogens"

showing 10 items of 100 documents

Human norovirus binding to select bacteria representative of the human gut microbiota

2016

Recent reports describe the ability of select bacterial strains to bind human norovirus, although the specificity of such interactions is unknown. The purpose of this work was to determine if a select group of bacterial species representative of human gut microbiota bind to human norovirus, and if so, to characterize the intensity and location of that binding. The bacteria screened included naturally occurring strains isolated from human stool (Klebsiella spp., Citrobacter spp., Bacillus spp., Enterococcus faecium and Hafnia alvei) and select reference strains (Staphylococcus aureus and Enterobacter cloacae). Binding in PBS was evaluated to three human norovirus strains (GII.4 New Orleans 2…

RNA viruses0301 basic medicinePhysiologyvirusesEnterococcus faeciumFimbrialcsh:MedicineBacillusPathology and Laboratory Medicinemedicine.disease_causePilusFecesBinding AnalysisCitrobacterKlebsiellaMedicine and Health SciencesElectron Microscopylcsh:ScienceCitrobacterMicroscopyMultidisciplinarybiologyChemistryBody FluidsBloodMedical MicrobiologyViral PathogensVirusesAnaerobic bacteriaPathogensAnatomyCell Binding AssayResearch ArticleCell BindingStaphylococcus aureusCell PhysiologyAnaerobic BacteriaResearch and Analysis MethodsMicrobiologyCalicivirusesMicrobiology03 medical and health sciencesEnterobacter cloacaemedicineHumansMicrobial PathogensChemical CharacterizationBiology and life sciencesBacteriaNoroviruslcsh:ROrganismsHafnia alveiCell Biologybiology.organism_classificationCulture MediaGastrointestinal Microbiome030104 developmental biologyFimbriae BacterialNorovirusMicrobial InteractionsTransmission Electron Microscopylcsh:QEnterobacter cloacaeBacteriaEnterococcus faeciumPLOS ONE
researchProduct

Cost-Effectiveness Analysis of Different Testing Strategies that Use Antibody Levels to Detect Chronic Hepatitis C in Blood Donors.

2016

Aim. We conducted a cost-effectiveness analysis of seven hepatitis C virus (HCV) testing strategies in blood donors. Methods. Three of the seven strategies were based on HCV diagnosis and reporting guidelines in Mexico and four were from previous and current recommendations outlined by the CDC. The strategies that were evaluated determine antibody levels according to the signal-to-cut-off (S/CO) ratio and use reflex Immunoblot (IMB) or HCV RNA tests to confirm true positive (TP) cases of chronic HCV infection. Costs were calculated from the perspective of the Mexican Institute of Social Security (IMSS). A decision tree model was developed to estimate the expected number of true positive cas…

RNA virusesDecision AnalysisPhysiologyEconomicsCost-Benefit AnalysisSocial Scienceslcsh:MedicineBlood DonorsHepacivirusmedicine.disease_causeBiochemistryHepatitis0302 clinical medicineImmune Physiology030212 general & internal medicineChroniclcsh:SciencePathology and laboratory medicinehealth care economics and organizationsMultidisciplinaryImmune System ProteinsCost–benefit analysisHepatitis C virusLiver DiseaseCost-effectiveness analysisMedical microbiologyHepatitis CHCV AntibodyInfectious DiseasesVirusesEngineering and TechnologyBlood Banks030211 gastroenterology & hepatologyPathogensInfectionManagement EngineeringResearch Articlemedicine.medical_specialtyGeneral Science & TechnologyHepatitis C virusImmunologyCost-Effectiveness AnalysisImmunoblottingChronic Liver Disease and CirrhosisMolecular Probe TechniquesAntibody levelResearch and Analysis MethodsMicrobiologyAntibodies03 medical and health sciencesChronic hepatitisHepatitis - CClinical ResearchInternal medicineparasitic diseasesmedicineHumansImmunoassaysMolecular Biology TechniquesSensitivity analysesMolecular BiologyMedicine and health sciencesBiology and life sciencesFlavivirusesbusiness.industryDecision Treeslcsh:RHepatitis C antibodyOrganismsViral pathogensProteinsHepatitis C ChronicHepatitis C AntibodiesHepatitis virusesEconomic AnalysisMicrobial pathogensHealth CareEmerging Infectious DiseasesCost Effectiveness ResearchHealth Care FacilitiesImmunologyImmunologic Techniqueslcsh:QbusinessDigestive Diseases
researchProduct

APOBEC4 Enhances the Replication of HIV-1

2016

APOBEC4 (A4) is a member of the AID/APOBEC family of cytidine deaminases. In this study we found a high mRNA expression of A4 in human testis. In contrast, there were only low levels of A4 mRNA detectable in 293T, HeLa, Jurkat or A3.01 cells. Ectopic expression of A4 in HeLa cells resulted in mostly cytoplasmic localization of the protein. To test whether A4 has antiviral activity similar to that of proteins of the APOBEC3 (A3) subfamily, A4 was co-expressed in 293T cells with wild type HIV-1 and HIV-1 luciferase reporter viruses. We found that A4 did not inhibit the replication of HIV-1 but instead enhanced the production of HIV-1 in a dose-dependent manner and seemed to act on the viral L…

RNA virusesMale0301 basic medicineMolecular biologylcsh:MedicineArtificial Gene Amplification and ExtensionCytidinePathology and Laboratory MedicineVirus ReplicationBiochemistryPolymerase Chain ReactionJurkat cellschemistry.chemical_compoundCytidine deaminationImmunodeficiency VirusesTranscription (biology)TestisMedicine and Health Scienceslcsh:SciencePromoter Regions GeneticMultidisciplinaryCytidineTransfectionEnzymesImmunoblot AnalysisMedical MicrobiologyDeaminationViral PathogensViruses293T cellsCell linesPathogensOxidoreductasesBiological culturesLuciferaseResearch ArticleMolecular Probe TechniquesDNA constructionBiologyMicrobiologyCell Line03 medical and health sciencesCytidine DeaminaseRetrovirusesHumansMicrobial PathogensHIV Long Terminal Repeat030102 biochemistry & molecular biologylcsh:RLentivirusHEK 293 cellsOrganismsBiology and Life SciencesHIVProteinsPromoterMolecular biologyResearch and analysis methodsMolecular biology techniques030104 developmental biologychemistryPlasmid ConstructionHIV-1Enzymologylcsh:QEctopic expressionCloningPLOS ONE
researchProduct

Impact of probiotic Saccharomyces boulardii on the gut microbiome composition in HIV-treated patients: A double-blind, randomised, placebo-controlled…

2017

Dysbalance in gut microbiota has been linked to increased microbial translocation, leading to chronic inflammation in HIV-patients, even under effective HAART. Moreover, microbial translocation is associated with insufficient reconstitution of CD4+T cells, and contributes to the pathogenesis of immunologic non-response. In a double-blind, randomised, placebo-controlled trial, we recently showed that, compared to placebo, 12 weeks treatment with probiotic Saccharomyces boulardii significantly reduced plasma levels of bacterial translocation (Lipopolysaccharide-binding protein or LBP) and systemic inflammation (IL-6) in 44 HIV virologically suppressed patients, half of whom (n = 22) had immun…

RNA virusesMale0301 basic medicinePlacebo-controlled studylcsh:MedicineHIV InfectionsGut floraPathology and Laboratory MedicineSystemic inflammationlaw.inventionPlacebosProbiotic0302 clinical medicineImmunodeficiency ViruseslawMedicine and Health SciencesMedicinelcsh:ScienceImmune ResponseMultidisciplinarybiologyMicrobiotaGenomicsMiddle AgedProbiòticsBacterial PathogensIntestinesSaccharomyces boulardiiMedical MicrobiologyViral PathogensVirusesFemale030211 gastroenterology & hepatologyPathogensmedicine.symptomResearch ArticleSaccharomyces boulardiiAdultImmunologyMicrobial GenomicsMicrobiologySaccharomyces03 medical and health sciencesSigns and SymptomsImmune systemDouble-Blind MethodDiagnostic MedicineRetrovirusesGeneticsVIH (Virus)HumansMicrobiomeMicrobial PathogensInflammationClostridiumBacteriabusiness.industryProbioticsGut BacteriaLentivirusLachnospiraceaelcsh:ROrganismsFungiBiology and Life SciencesHIVbiology.organism_classificationYeast030104 developmental biologyImmunologylcsh:QMicrobiomebusinessPLoS ONE
researchProduct

An Open-Label Trial of 12-Week Simeprevir plus Peginterferon/Ribavirin (PR) in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 1 (GT1)

2016

Background: Shortening duration of peginterferon-based HCV treatment reduces associated burden for patients. Primary objectives of this study were to assess the efficacy against the minimally acceptable response rate 12 weeks post-treatment (SVR12) and safety of simeprevir plus PR in treatment-naïve HCV GT1 patients treated for 12 weeks. Additional objectives included the investigation of potential associations of rapid viral response and baseline factors with SVR12. Methods: In this Phase III, open-label study in treatment-naïve HCV GT1 patients with F0-F2 fibrosis, patients with HCV-RNA 12-week regimen. Conclusions: Overall SVR12 rate (66%) was below the target of 80%, indicating that sho…

RNA virusesMale0301 basic medicineSimeprevirDecision AnalysisPsychologie appliquéelcsh:MedicineHepacivirusmedicine.disease_causeTherapy naivechemistry.chemical_compoundMathematical and Statistical Techniques0302 clinical medicineRecurrenceSimeprevirlcsh:SciencePathology and laboratory medicineMultidisciplinaryHepatitis C virusPharmaceuticsHepatitis CMedical microbiologyViral LoadMiddle AgedSciences bio-médicales et agricolesPEGINTERFERON/RIBAVIRINHepatitis C3. Good healthTreatment OutcomeResearch DesignVirusesPhysical SciencesRegression AnalysisEngineering and TechnologyFemale030211 gastroenterology & hepatologyPathogensManagement EngineeringBiologieViral loadStatistics (Mathematics)HumanResearch ArticleAdultmedicine.medical_specialtyGenotypeClinical Research DesignHepatitis C virusResearch and Analysis MethodsMicrobiologyAntiviral AgentsYoung Adult03 medical and health sciencesDrug TherapyVirologyRibavirinmedicineHumansddc:610Statistical MethodsAgedAntiviral AgentMedicine and health sciencesHepaciviruFlavivirusesbusiness.industryRibavirinDecision Treeslcsh:ROrganismsViral pathogensBiology and Life Sciencesmedicine.diseaseFibrosisVirologyHepatitis virusesMicrobial pathogensClinical trial030104 developmental biologychemistryFamily medicineMultivariate Analysislcsh:QAdverse EventsbusinessMathematicsViral Transmission and InfectionDevelopmental BiologyPLOS ONE
researchProduct

A model for rapid, active surveillance for medically-attended acute gastroenteritis within an integrated health care delivery system

2018

Background This study presents a novel methodology for estimating all-age, population-based incidence rates of norovirus and other pathogens that contribute to acute gastroenteritis in the United States using an integrated healthcare delivery system as a surveillance platform. Methods All cases of medically attended acute gastroenteritis within the delivery system were identified from April 1, 2014 through September 30, 2016. A sample of these eligible patients were selected to participate in two phone-based surveys and to self-collect a stool sample for laboratory testing. To ascertain household transmission patterns, information on household members with acute gastroenteritis was gathered…

RNA virusesMale0301 basic medicineTime FactorsEpidemiologyEthnic grouplcsh:MedicineSurveysPathology and Laboratory Medicinemedicine.disease_causeGeographical locationsOregonFeces0302 clinical medicineEpidemiologyMedicine and Health SciencesSampling (medicine)030212 general & internal medicineChildlcsh:Scienceeducation.field_of_studyMultidisciplinaryDelivery of Health Care IntegratedMiddle AgedTelephonesGastroenteritisDiarrheaInfectious DiseasesResearch DesignMedical MicrobiologyViral PathogensChild PreschoolVirusesEpidemiological MonitoringEngineering and TechnologyFemalePathogensEpidemiological Monitoringmedicine.symptomResearch ArticleDiarrheaAdultmedicine.medical_specialtyInfectious Disease ControlAdolescent030106 microbiologyPopulationEquipmentSample (statistics)Gastroenterology and HepatologyDisease SurveillanceResearch and Analysis MethodsMicrobiologyCalicivirusesYoung Adult03 medical and health sciencesSigns and SymptomsDiagnostic MedicinemedicineHumanseducationMicrobial PathogensAgedCommunication EquipmentSurvey Researchbusiness.industryNoroviruslcsh:ROrganismsBiology and Life SciencesUnited StatesInfectious Disease SurveillanceFamily medicineNorth AmericaNorovirusFeasibility Studieslcsh:QPeople and placesbusinessFollow-Up StudiesPLOS ONE
researchProduct

Vertical transmission of naturally occurring Bunyamwera and insect-specific flavivirus infections in mosquitoes from islands and mainland shores of L…

2018

Background Many arboviruses transmitted by mosquitoes have been implicated as causative agents of both human and animal illnesses in East Africa. Although epidemics of arboviral emerging infectious diseases have risen in frequency in recent years, the extent to which mosquitoes maintain pathogens in circulation during inter-epidemic periods is still poorly understood. This study aimed to investigate whether arboviruses may be maintained by vertical transmission via immature life stages of different mosquito vector species. Methodology We collected immature mosquitoes (egg, larva, pupa) on the shores and islands of Lake Baringo and Lake Victoria in western Kenya and reared them to adults. Mo…

RNA virusesMale0301 basic medicineViral DiseasesAnopheles GambiaevirusesAnopheles gambiaeRC955-962Marine and Aquatic SciencesDisease VectorsPathology and Laboratory MedicineMosquitoes0302 clinical medicineAedesArctic medicine. Tropical medicineMedicine and Health SciencesChikungunya VirusbiologyPupaAnophelesEukaryotavirus diseasesGene PoolInsectsCulexInfectious DiseasesArboviral InfectionsMedical MicrobiologyViral PathogensLarvaVirusesFemalePublic aspects of medicineRA1-1270PathogensResearch ArticleFreshwater EnvironmentsArthropodaAlphaviruses030231 tropical medicineZoologyMosquito VectorsAedes aegyptiAedes AegyptiMicrobiologyArbovirusTogaviruses03 medical and health sciencesAedes luteocephalusSpecies SpecificityAnophelesparasitic diseasesCulex pipiensGeneticsmedicineAnimalsBunyamwera virusMicrobial PathogensAedesEvolutionary BiologyLife Cycle StagesPopulation BiologyFlavivirusEcology and Environmental SciencesfungiOrganismsPublic Health Environmental and Occupational HealthBiology and Life SciencesAquatic EnvironmentsBodies of Watermedicine.diseasebiology.organism_classificationInvertebratesKenyaInsect VectorsSpecies InteractionsLakes030104 developmental biologyVector (epidemiology)Earth SciencesArbovirusesPopulation GeneticsPLOS Neglected Tropical Diseases
researchProduct

Sequential Cross-Sectional Surveys in Orange Farm, a Township of South Africa, Revealed a Constant Low Voluntary Medical Male Circumcision Uptake amo…

2016

Background WHO recommends a male circumcision (MC) prevalence rate higher than 80% to have a substantial impact on the HIV-AIDS epidemic in Eastern and Southern Africa. Orange Farm, a township in South Africa, has a free-for-service voluntary medical male circumcision (VMMC) clinic in operation since 2008. Following an intense campaign from 2008 to 2010, MC prevalence rate increased to 55.4% (ANRS-12126). Ongoing and past VMMC campaigns focused on youths, through school talks, and adults at a community level. The main objective of the study was to assess the change in MC prevalence rate among adults aged 18–19 and 18–49 years in the past 5 years. Methods A cross-sectional survey (ANRS-12285…

RNA virusesMaleCross-sectional studyEpidemiologyPrevalenceSocial Scienceslcsh:MedicineHIV InfectionsOrange (colour)Pathology and Laboratory MedicineGeographical locationsCultural AnthropologySouth Africa0302 clinical medicineImmunodeficiency VirusesSociologyEnvironmental protectionCircumcisionMedicine and Health SciencesPrevalenceMedicine030212 general & internal medicineYoung adultReproductive System Procedureslcsh:ScienceMultidisciplinarySchoolsMiddle Aged3. Good healthReligionMale circumcisionMedical MicrobiologyHIV epidemiologyViral PathogensVirusesInfectious diseasesPathogens0305 other medical scienceDemand creationResearch ArticleAdultAdolescentSurgical and Invasive Medical ProceduresViral diseasesMicrobiologyEducation03 medical and health sciencesYoung AdultRetrovirusesAdultsHumansSex organMicrobial Pathogens030505 public healthbusiness.industryLentiviruslcsh:ROrganismsBiology and Life SciencesHIVPatient Acceptance of Health CareCross-Sectional StudiesCircumcision MaleTurnoverAge GroupsAnthropologyPeople and PlacesAfricaPopulation Groupingslcsh:Qbusiness[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyDemography
researchProduct

The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib

2020

Background and aims The present study aims to investigate the role of the prognostic nutritional index (PNI) on survival in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib. Methods This multicentric study included a training cohort of 194 HCC patients and three external validation cohorts of 129, 76 and 265 HCC patients treated with Sorafenib, respectively. The PNI was calculated as follows: 10 × serum albumin (g/dL) + 0.005 × total lymphocyte count (per mm3). Univariate and multivariate analyses were performed to investigate the association between the covariates and the overall survival (OS). Results A PNI cut-off value of 31.3 was established using the ROC an…

RNA virusesMaleEtiologyCancer TreatmentHepacivirusKaplan-Meier EstimateBiochemistryCohort StudiesWhite Blood CellsMathematical and Statistical TechniquesRetrospective StudieAnimal CellsAdult; Aged; Aged 80 and over; Antineoplastic Agents; Carcinoma Hepatocellular; Cohort Studies; Female; Humans; Italy; Kaplan-Meier Estimate; Liver Neoplasms; Lymphocyte Count; Male; Middle Aged; Prognosis; Retrospective Studies; Serum Albumin; Sorafenib; Nutrition AssessmentMedicine and Health Sciences80 and overLymphocytesPathology and laboratory medicineAged 80 and overHepatitis C virusLiver DiseasesStatisticsQLiver NeoplasmsRMedical microbiologyMiddle AgedSorafenibPrognosisOncologyItalyLiver NeoplasmPhysical SciencesVirusesMedicineFemalePathogensCellular TypesHumanResearch ArticleAdultHepatitis B virusCarcinoma HepatocellularImmune CellsScienceImmunologyAntineoplastic AgentsGastroenterology and HepatologySerum Albumin ...Research and Analysis MethodsCarcinomasMicrobiologyAlbuminsGastrointestinal TumorsHumansLymphocyte CountStatistical MethodsSerum AlbuminAgedRetrospective StudiesBlood CellsAdult Aged 80 and over Antineoplastic Agents Carcinoma Hepatocellular Cohort Studies Female Humans Italy Kaplan-Meier Estimate Liver Neoplasms Lymphocyte Count Male Middle Aged Prognosis Retrospective Studies Serum Albumin Sorafenib Nutrition AssessmentBiology and life sciencesFlavivirusesCarcinomaViral pathogensOrganismsCancers and NeoplasmsProteinsHepatocellularHepatocellular CarcinomaCell Biologyprognostic nutritional index (PNI) hepatocellular carcinoma (HCC) sorafenib. survival mRECISTHepatitis virusesMicrobial pathogensNutrition AssessmentMultivariate AnalysisCohort StudieMathematics
researchProduct

Evolution of patients’ socio-behavioral characteristics in the context of DAA: Results from the French ANRS CO13 HEPAVIH cohort of HIV-HCV co-infecte…

2018

International audience; BACKGROUND:Direct-acting antivirals (DAA) have dramatically increased HCV cure rates with minimal toxicity in HIV-HCV co-infected patients. This study aimed to compare the socio-behavioral characteristics of patients initiating pegylated-interferon (PEG-IFN)-based HCV treatment with those of patients initiating DAA-based treatment.METHODS:ANRS CO13 HEPAVIH is a national multicenter prospective cohort started in 2005, which enrolled 1,859 HIV-HCV co-infected patients followed up in French hospital outpatient units. Both clinical/biological and socio-behavioral data were collected during follow-up. We selected patients with socio-behavioral data available before HCV tr…

RNA virusesMaleHealth BehaviorSocial Scienceslcsh:MedicineHIV InfectionsHepacivirusGeographical locationsChronic Liver Disease0302 clinical medicineRisk FactorsPrevalencePsychologyAlcohol consumptionProspective Studies030212 general & internal medicineYoung adultProspective cohort studylcsh:SciencePathology and laboratory medicinemedia_commonChronic hepatitisDrug injectionClinical Trials as TopicMultidisciplinarybiologyPharmaceuticsCoinfectionHepatitis C virusLiver Diseasesvirus diseasesMedical microbiologyMiddle AgedPrognosisHepatitis CAddicts3. Good healthEuropeBehavioral PharmacologyDrug usersVirusesCohortFemale030211 gastroenterology & hepatologyDrug therapyFrancePathogensResearch ArticleAdultDrugmedicine.medical_specialtySubstance-Related Disordersmedia_common.quotation_subjectLiver fibrosisAddictionContext (language use)Gastroenterology and HepatologyMicrobiologyAntiviral AgentsYoung Adult03 medical and health sciencesPharmacotherapyRecreational Drug UseInternal medicinemedicineHumansEuropean UnionNutritionAgedCannabisMedicine and health sciencesPharmacologyBiology and life sciencesFlavivirusesbusiness.industrylcsh:ROrganismsViral pathogensHIVbiology.organism_classificationHepatitis virusesdigestive system diseasesMicrobial pathogensDiet[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologielcsh:Q[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieCannabisPeople and placesbusiness
researchProduct